Holen Sie sich die Stockscreener-App
5.07
6.28%
-0.34
Handel nachbörslich:
5.08
0.010
+0.20%
Schlusskurs vom Vortag:
$5.41
Offen:
$5.43
24-Stunden-Volumen:
75,471
Relative Volume:
0.15
Marktkapitalisierung:
$6.57M
Einnahmen:
$6,200
Nettoeinkommen (Verlust:
$-24.48M
KGV:
-1.0445
EPS:
-4.8539
Netto-Cashflow:
$-4.92M
1W Leistung:
-13.04%
1M Leistung:
-17.56%
6M Leistung:
-95.94%
1J Leistung:
-98.12%
1-Tages-Spanne:
$4.8601
$5.44
1-Wochen-Bereich:
$4.8601
$6.21
52-Wochen-Spanne:
$3.309
$1,050.36
Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile
Firmenname
Aspire Biopharma Holdings Inc
Sektor
Branche
Telefon
561-704-8527
Adresse
23150 FASHION DRIVE, SUITE 232, ESTERO
Compare ASBP vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ASBP
Aspire Biopharma Holdings Inc
|
5.07 | 7.01M | 6,200 | -24.48M | -4.92M | -4.8539 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Aspire Biopharma Holdings Inc Aktie (ASBP) Neueste Nachrichten
Aspire Biopharma Company Profile & Introduction - Moomoo
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - The Augusta Chronicle
Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements - The Destin Log
ASBP Stock Price, Quote & Chart | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill
Why Kulicke And Soffa Industries Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket - Sahm
ASBP Financials: Income Statement, Balance Sheet & Cash Flow | Aspire Biopharma Holdings Inc - Stock Titan
Aspire Biopharma Holdings, Inc. 1Q 2026: Revenue $28.35K, Net loss $(3.22M), EPS $(20.57) — 10-Q Summary - TradingView
Aspire Biopharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Aspire Biopharma Announces 1-for-30 Reverse Stock Split - TipRanks
Aspire Biopharma (ASBP) Authorizes $5M Share Repurchase Program - Insider Monkey
Ardsley-related holders report ≤5% in Aspire Biopharma (ASBP) - Stock Titan
Aspire Biopharma (ASBP) asks shareholders to approve pre-funded warrants and share adjustments - Stock Titan
TradingKey - TradingKey
ASBP Stock Jumps 21% On Buyback Offer – Retail Believes Every Dip’s A Buying Opportunity - MSN
Warrant and dilution approvals on agenda at Aspire Biopharma (ASBP) - Stock Titan
Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio - ACCESS Newswire
Sublingual Drug Reformulator Expands into Caffine Market & Gets Capital Injection - Streetwise Reports
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm
4 High Volatility Penny Stocks Technical Analysis | ASBP, OCG, GPUS & LUCY Stock Forecast (j9FZjuwfde) - Fathom Journal
Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo - ACCESS Newswire
Nasdaq compliance push: Aspire Biopharma enacts 1-for-30 split - Stock Titan
These stocks are the most active in today's session - ChartMill
Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue - ACCESS Newswire
Aspire Biopharma to implement 1-for-30 reverse stock split By Investing.com - Investing.com Nigeria
Aspire Biopharma to implement 1-for-30 reverse stock split - Investing.com
Aspire Biopharma Holdings, Inc. Announces Reverse Stock Split Approval - geneonline.com
Why Qualcomm Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Sahm
ASBP: A Platform Approach to Drug Delivery with an Unconventional Path to Commercialization - Zacks Small Cap Research
ASBP - Finviz
LCID, ASBP, WLDS stocks hit 52-week lows: What drove the selloff? - MSN
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
ASBP bulls back in control after 78% crash: What changed? - MSN
Aspire Biopharma announces $5M share repurchase program - MSN
Aspire Biopharma regains Nasdaq minimum bid price compliance - MSN
Aspire Biopharma (ASBP) asks holders to approve warrants, $0.00001 exercise price - Stock Titan
Finanzdaten der Aspire Biopharma Holdings Inc-Aktie (ASBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):